Variant report
Variant | esv3396639 |
---|---|
Chromosome Location | chr3:21850098-21853996 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs150347211 | chr3:21850099-21850100 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs7646597 | chr3:21850106-21850107 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs557748305 | chr3:21850111-21850112 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs6802746 | chr3:21850118-21850119 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs540020671 | chr3:21850131-21850132 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs555460690 | chr3:21850145-21850146 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs573732033 | chr3:21850152-21850153 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs188044666 | chr3:21850160-21850161 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs145022492 | chr3:21850174-21850175 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs371098805 | chr3:21850210-21850211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs376632344 | chr3:21850212-21850213 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs561781902 | chr3:21850213-21850214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs6550626 | chr3:21850242-21850243 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs75044542 | chr3:21850278-21850279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs376305552 | chr3:21850280-21850281 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs549261734 | chr3:21850285-21850286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs573440955 | chr3:21850297-21850298 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs567428976 | chr3:21850311-21850312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs550770858 | chr3:21850314-21850315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs181389531 | chr3:21850326-21850327 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs549861867 | chr3:21850328-21850329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs149105989 | chr3:21850346-21850347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs143167325 | chr3:21850350-21850351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs558049132 | chr3:21850360-21850361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs184591455 | chr3:21850364-21850365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs533996333 | chr3:21850368-21850369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs570932224 | chr3:21850370-21850371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs138939443 | chr3:21850388-21850389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs573875997 | chr3:21850391-21850392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs59212732 | chr3:21853808-21853809 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
31 | rs540323824 | chr3:21853809-21853810 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
32 | rs542026020 | chr3:21853820-21853821 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
33 | rs561713213 | chr3:21853846-21853847 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
34 | rs542704275 | chr3:21853850-21853851 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
35 | rs528874137 | chr3:21853852-21853853 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
36 | rs544956134 | chr3:21853884-21853885 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
37 | rs563007917 | chr3:21853947-21853948 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
38 | rs112687514 | chr3:21853958-21853959 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
39 | rs143273196 | chr3:21853959-21853960 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
40 | rs560726995 | chr3:21853961-21853962 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
41 | rs375462494 | chr3:21853976-21853977 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
42 | rs527827985 | chr3:21853983-21853984 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Breast cancer | 17133270 | CNVD |
Developmental delay | 21147756 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 20688739 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:21844800-21850200 | Weak transcription | Aorta | Aorta |
2 | chr3:21850000-21850400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr3:21850200-21850400 | Enhancers | Aorta | Aorta |
4 | chr3:21853800-21854400 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |